Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NWBO |
---|---|---|
09:32 ET | 14515 | 0.4688 |
09:34 ET | 3400 | 0.4688 |
09:36 ET | 16100 | 0.4699 |
09:38 ET | 14950 | 0.4699 |
09:39 ET | 142200 | 0.465 |
09:41 ET | 41076 | 0.472 |
09:43 ET | 111771 | 0.482515 |
09:45 ET | 11498 | 0.4801 |
09:48 ET | 7625 | 0.47255 |
09:50 ET | 9265 | 0.468 |
09:52 ET | 126003 | 0.4651 |
09:54 ET | 2500 | 0.471 |
09:56 ET | 2800 | 0.4744 |
09:57 ET | 4500 | 0.47304 |
10:01 ET | 2600 | 0.4744 |
10:03 ET | 4000 | 0.47 |
10:06 ET | 15200 | 0.47 |
10:08 ET | 2500 | 0.47 |
10:10 ET | 5100 | 0.4722 |
10:12 ET | 2500 | 0.47 |
10:15 ET | 5000 | 0.47 |
10:19 ET | 2500 | 0.47 |
10:24 ET | 5100 | 0.47 |
10:28 ET | 2500 | 0.47 |
10:32 ET | 2500 | 0.47 |
10:33 ET | 10500 | 0.4766 |
10:35 ET | 2800 | 0.47 |
10:37 ET | 2500 | 0.47231 |
10:39 ET | 2500 | 0.47 |
10:44 ET | 2500 | 0.47 |
10:48 ET | 2100 | 0.475 |
10:50 ET | 8400 | 0.4726 |
10:53 ET | 12500 | 0.4725 |
10:57 ET | 14000 | 0.475 |
11:00 ET | 24744 | 0.4758 |
11:02 ET | 5200 | 0.478 |
11:08 ET | 2500 | 0.478 |
11:09 ET | 15000 | 0.478 |
11:11 ET | 2500 | 0.478 |
11:15 ET | 2500 | 0.478 |
11:20 ET | 13000 | 0.478 |
11:22 ET | 26150 | 0.48052 |
11:24 ET | 364 | 0.47968 |
11:26 ET | 9000 | 0.48 |
11:27 ET | 23425 | 0.48 |
11:31 ET | 3500 | 0.4725 |
11:38 ET | 2850 | 0.4725 |
11:40 ET | 1600 | 0.47625 |
11:42 ET | 2500 | 0.4725 |
11:45 ET | 30794 | 0.47625 |
11:47 ET | 2500 | 0.4725 |
11:49 ET | 675 | 0.479925 |
11:51 ET | 21100 | 0.4798 |
11:54 ET | 2500 | 0.4725 |
12:00 ET | 2500 | 0.4725 |
12:03 ET | 300 | 0.4766 |
12:05 ET | 2500 | 0.4725 |
12:07 ET | 425 | 0.475 |
12:14 ET | 2500 | 0.4725 |
12:18 ET | 3000 | 0.472 |
12:20 ET | 2600 | 0.475 |
12:23 ET | 15000 | 0.475 |
12:27 ET | 2500 | 0.475 |
12:30 ET | 29500 | 0.4758 |
12:32 ET | 640 | 0.475 |
12:34 ET | 2600 | 0.4766 |
12:36 ET | 6500 | 0.4788 |
12:41 ET | 3300 | 0.4779 |
12:43 ET | 4000 | 0.4788 |
12:45 ET | 200 | 0.47892 |
12:52 ET | 5500 | 0.4788 |
12:59 ET | 2500 | 0.4765 |
01:08 ET | 5400 | 0.4765 |
01:17 ET | 9901 | 0.47625 |
01:24 ET | 7000 | 0.475 |
01:26 ET | 2500 | 0.475 |
01:28 ET | 5000 | 0.475 |
01:30 ET | 556 | 0.475 |
01:33 ET | 2500 | 0.475 |
01:37 ET | 500 | 0.4799 |
01:44 ET | 12500 | 0.4799 |
01:46 ET | 565 | 0.475 |
01:51 ET | 2500 | 0.475 |
02:00 ET | 2600 | 0.47696 |
02:02 ET | 5000 | 0.4799 |
02:06 ET | 3056 | 0.475 |
02:11 ET | 100 | 0.4799 |
02:13 ET | 3525 | 0.4765 |
02:20 ET | 2500 | 0.4765 |
02:22 ET | 2600 | 0.4782 |
02:24 ET | 2000 | 0.47888 |
02:26 ET | 3202 | 0.4765 |
02:31 ET | 2500 | 0.4765 |
02:36 ET | 1478 | 0.4765 |
02:38 ET | 2500 | 0.4765 |
02:44 ET | 2853 | 0.4765 |
02:45 ET | 1000 | 0.4799 |
02:47 ET | 2663 | 0.4765 |
02:51 ET | 2653 | 0.4765 |
02:56 ET | 2639 | 0.4765 |
02:58 ET | 500 | 0.4782 |
03:00 ET | 9689 | 0.4765 |
03:02 ET | 1345 | 0.4769 |
03:05 ET | 4255 | 0.478762 |
03:07 ET | 2677 | 0.475 |
03:12 ET | 2957 | 0.475 |
03:16 ET | 5843 | 0.47 |
03:20 ET | 2606 | 0.4701 |
03:21 ET | 2699 | 0.4725 |
03:23 ET | 5400 | 0.4725 |
03:25 ET | 2500 | 0.4725 |
03:27 ET | 2500 | 0.4725 |
03:32 ET | 8775 | 0.478737 |
03:34 ET | 6100 | 0.4725 |
03:36 ET | 2750 | 0.47652 |
03:39 ET | 2500 | 0.475 |
03:41 ET | 4500 | 0.47747 |
03:43 ET | 2600 | 0.475 |
03:45 ET | 5500 | 0.475 |
03:48 ET | 2500 | 0.475 |
03:50 ET | 7400 | 0.4725 |
03:52 ET | 2500 | 0.4725 |
03:56 ET | 5105 | 0.478713 |
03:57 ET | 12600 | 0.4765 |
03:59 ET | 2080 | 0.477 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Northwest Biotherapeutics Inc | 567.6M | -8.3x | --- |
Cabaletta Bio Inc | 570.1M | -7.4x | --- |
Cogent Biosciences Inc | 574.6M | -2.5x | --- |
Lyell Immunopharma Inc | 559.0M | -2.4x | --- |
Olema Pharmaceuticals Inc | 549.6M | -4.6x | --- |
Mineralys Therapeutics Inc | 547.9M | -6.2x | --- |
Northwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing personalized immune therapies for cancer. It has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The Company's product line includes DCVax-L and DCVax-Direct. DCVax-L is designed to treat solid tumor cancers in which the tumors can be surgically removed. It has completed a 331-patient international Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM). DCVax-Direct, is designed to treat inoperable solid tumors. A 40-patient Phase I trial has been completed and included treatment of a diverse range of more than a dozen types of cancers. The Company’s wholly owned subsidiaries include Flaskworks, LLC, Northwest Biotherapeutics Limited, Aracaris Capital, Ltd, Northwest Biotherapeutics B.V., and NW Bio GmbH.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $567.6M |
---|---|
Revenue (TTM) | $1.9M |
Shares Outstanding | 1.2B |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.66 |
EPS | $-0.06 |
Book Value | $-0.04 |
P/E Ratio | -8.3x |
Price/Sales (TTM) | 293.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,152.74% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.